A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents
Anton B, Leff P.
Laboratory of Molecular Neurobiology and Addictive Neurochemistry,
National Institute of Psychiatry,
Ramon de la Fuente Muniz, Calz.,
Mexico-Xochimilco #101,
Mexico D.F.C.P. 14370, Mexico.
Vaccine. 2006 Feb 8;


Both pre-clinical and clinical studies make feasible the use of vaccines as novel therapeutic medications to treat drug addiction. No reports to date have shown the development of structural models of opiate candidate vaccines for treating human addiction to such compounds. Here we report on the initial development of a novel structural formulation of a bi-valent vaccine against morphine/heroin. This vaccine was able to trigger and establish a high titer antibody response to haptenized drug with antibodies displaying equivalent specificities for both morphine and heroin. Such antibodies did not cross-recognize structurally dissimilar opiate medications. Furthermore, the evaluation of the potential therapeutic effectiveness of this vaccine was targeted to relapse prevention using a schedule of heroin delivery in the rat self-administration model. Antibodies against heroin blocked its reinforcing effects in rodents. The type of carrier protein used in this vaccine allows further evaluation of its potential therapeutic value for preventing relapse to heroin addiction in humans.
Dutch heroin
Heroin in Song
Heinrich Dreser
Heroin in Vienna
Intranasal heroin
Monkeys on heroin
Songs about heroin
Intravenous heroin
Heroin maintenance
Pharmaceutical heroin
Heroin and nitric oxide
Heroin versus morphine
The prescription for heroin
Heroin, GABAA and the NAcc
Heroin: A Drug Fit For Heroes?

and further reading

Future Opioids
BLTC Research
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family